Prevention and immunisation of cervical cancer amongst school girls in Vanuatu

Not Applicable

Completed

• Conditions: cervical cancer; Cancer - Cervical (cervix)

• Registration Number: ACTRN12611001036909
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1000

Inclusion Criteria

age 9 - 12 years old school girls

Exclusion Criteria

1. younger than 9 and older than 12 women
2. who currently receive any immunology modifier meditation.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ptake of HPV vaccination: percentage of 10-12 year old girls recruited in the study.[one year]

Secondary Outcome Measures

Name	Time	Method
Personal card record systems. This is to verify that the participants return back for the 3 shots of vaccine within the nominated time period.[one year];Relationship of age and nutrition with the immune responses to HPV infection. Sera collected pre and post immunisation, together with the participant personal information such as weight and height will be used to assess this information.[one year];HPV antibody test for the vaccine using ELISA assay. The assay demonstrates the presence of type specific IgG antibody present in the sera post immunisation. All participants immunised with Cervarix should demonstrate the presence of HPV 16 and HPV 18 antibodies.[6 months]